SAHPRA

5 November 2025

Aspen's Mounjaro expansion plans promise to enhance diabetes and weight management treatment in Sub-Saharan Africa soon.

15 October 2025

Aspen shares soar following the approval of Mounjaro for weight loss in South Africa. Discover the impact on obesity management.

15 October 2025

Understand the impact of the surge in illicit medicines on public health in South Africa and the measures being taken to protect patients.

2 October 2025

Understand the risks of inadequate medical device regulation and why oversight is crucial for patient safety in South Africa.

19 August 2025

Regulatory delays are hindering Africa's R1.25-trillion pharmaceutical manufacturing goals and access to markets.

7 August 2025

Cipla Medpro faces claims that it failed to inform patients properly about Tavaloxx side effects affecting health outcomes.

16 July 2025

Explore the future of local medicine manufacturing as Sahpra fast-tracks evaluation to secure South Africa's national supply.

2 July 2025

While the COVID-19 pandemic has subsided from its peak, the virus continues to circulate globally. SA experts demand vaccine access.

29 June 2025

Explore the revolutionary Twice-Yearly HIV Jab, a potential game-changer in HIV prevention that raises important affordability questions.

29 June 2025

Adcock Ingram's Urizone receives legal protection as the court halts Cipla's Furizome, citing trademark infringement.

17 October 2024

The SA Health Products Regulatory Authority (SAHPRA) has appealed to the National Treasury for more funding, warning of operational risks due to over-reliance on fee income.

Search the archive

Browse by month